News archive 2010
December
| Watson chewable contraceptive approved | 23 Dec 2010 |
| Novartis blood pressure drug approved | 23 Dec 2010 |
| New FDA approval for Merck's Gardasil | 23 Dec 2010 |
| EMA 'road map' to 2015 launched | 23 Dec 2010 |
| Biogen targets neurodegenerative diseases | 22 Dec 2010 |
November
| Basilea awarded $130m in J&J dispute | 30 Nov 2010 |
| Merck gets new CEO | 30 Nov 2010 |
| Industry responds to UK growth review | 30 Nov 2010 |
| Penn Pharma appoints new CEO | 30 Nov 2010 |
| Creston to acquire Cooney/Waters businesses | 30 Nov 2010 |
October
| Savient shares fall on failure to find buyer | 29 Oct 2010 |
| Celgene earnings rise | 29 Oct 2010 |
| Astellas files lawsuit against Nycomed | 28 Oct 2010 |
| Generics and legal costs affect AZ profits | 28 Oct 2010 |
| New US pharma firm debuts | 28 Oct 2010 |
September
| Senate investigating CVS Caremark | 30 Sep 2010 |
| MWW's Wadler moves to Zeno | 30 Sep 2010 |
| Quintiles, HKPI and Ramco form Egyptian JV | 30 Sep 2010 |
| ThromboGenics signs deal with MSD Biologics | 30 Sep 2010 |
| New clinical trial rules from FDA | 29 Sep 2010 |
August
| Priority review for stroke drug | 31 Aug 2010 |
| DVT drug performs well in trial | 31 Aug 2010 |
| Procoralan reduces heart failure deaths | 31 Aug 2010 |
| S-A offers $18.5bn for Genzyme | 31 Aug 2010 |
| Genentech cancer drug delayed | 31 Aug 2010 |
July
| Celgene profit up on Revlimid sales | 29 Jul 2010 |
| FDA approves drug for drooling | 29 Jul 2010 |
| Counterfeit medicines summit in US | 29 Jul 2010 |
| S-A profits reach €2.49bn for Q2 | 29 Jul 2010 |
| Pfizer launches online men's health clinic | 29 Jul 2010 |
June
| US court upholds Crestor patent | 30 Jun 2010 |
| Celgene to buy biotech company | 30 Jun 2010 |
| Bill would expand pharmacists' role | 30 Jun 2010 |
| Effexor XR generic approved | 30 Jun 2010 |
| Germany approves drug price cut bill | 30 Jun 2010 |
May
| Novartis' patupilone fails phase III trial | 27 May 2010 |
| New R&D roles at Pfizer and AZ | 27 May 2010 |
| NICE issues first biosimilar recommendation | 26 May 2010 |
| EMA grants CVD therapy ATMP certificate | 26 May 2010 |
| Consultancy to lead FDA review process | 26 May 2010 |
April
| Schwarz pays $22m in false claims case | 29 Apr 2010 |
| AZ net profit of $2.8bn for Q1 | 29 Apr 2010 |
| Vaccines help sanofi-aventis Q1 growth | 29 Apr 2010 |
| Industry conference addresses joint working | 28 Apr 2010 |
| Witty reports sustained growth for GSK | 28 Apr 2010 |
March
| Healthcare social media group unconference | 31 Mar 2010 |
| GSK's Duodart receives approval in Europe | 31 Mar 2010 |
| New senior hires and promotions at S&H | 31 Mar 2010 |
| Biotech and vaccines focus for sanofi-aventis | 31 Mar 2010 |
| EC approves Roche's Xeloda for colon cancer | 31 Mar 2010 |
February
| GSK hits back over Avandia | 26 Feb 2010 |
| Shire's Replagal is fast-tracked by the FDA | 25 Feb 2010 |
| Avastin hope in advanced ovarian cancer | 25 Feb 2010 |
| FDA approves Pfizer's infant IPD vaccine | 25 Feb 2010 |
| NICE recommends soft tissue cancer drug | 25 Feb 2010 |
January
| Porter Novelli appoints Sally Ward as MD | 28 Jan 2010 |
| AstraZeneca to cut 8,000 jobs | 28 Jan 2010 |
| Positive results for GSK's rotavirus vaccine | 28 Jan 2010 |
| Simon Jose appointed as new head of ABPI | 28 Jan 2010 |
| Movetis launches Resolor in Germany | 27 Jan 2010 |